The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials

Chapters:
7:43 Gene therapy targets
15:16 Nucleocytoplasmic transport
17:37 Neuroinflammatory pathways
19:58 Immune-mediated ALS therapies
24:17 Highlight of platform trial design
28:55 Cellular stress
33:09 Muscle targets
35:18 Stem cell therapies
37:44 ALS clinical trials unit
39:30 Questions